Elevance Health (ELV): Price and Financial Metrics

ELV POWR Grades

• ELV scores best on the Value dimension, with a Value rank ahead of 85.71% of US stocks.
• The strongest trend for ELV is in Stability, which has been heading down over the past 177 days.
• ELV's current lowest rank is in the Momentum metric (where it is better than 28.39% of US stocks).

ELV Stock Summary

• ELV has a higher market value than 97.97% of US stocks; more precisely, its current market capitalization is $105,358,134,957.
• ELEVANCE HEALTH INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 88.85% of US listed stocks.
• In terms of volatility of its share price, ELV is more volatile than merely 2.2% of stocks we're observing.
• If you're looking for stocks that are quantitatively similar to ELEVANCE HEALTH INC, a group of peers worth examining would be TJX, MDLZ, BKNG, LOW, and HDB.
• Visit ELV's SEC page to see the company's official filings. To visit the company's web site, go to www.antheminc.com.

ELV Valuation Summary

• ELV's price/sales ratio is 0.6; this is 85% lower than that of the median Healthcare stock.
• Over the past 243 months, ELV's price/sales ratio has gone down 0.

Below are key valuation metrics over time for ELV.

ELV Growth Metrics

Its 3 year net income to common stockholders growth rate is now at 56.51%.
• The 2 year cash and equivalents growth rate now stands at 15.27%.
• Its 3 year price growth rate is now at 111.09%.

The table below shows ELV's growth in key financial areas (numbers in millions of US dollars).